METHODS, COMPOSITIONS AND DEVICES FOR TREATING CANCER WITH ILLUDOFULVENES

作者: Kelner Michael

DOI:

关键词:

摘要: The present invention relates to compositions, methods and devices for treating cancer with illudofulvenes including detect the expression levels of genes encoding biomarkers in patients predict responsiveness illudofulvenes.

参考文章(7)
Michael Kelner, Affinity medicant conjugate ,(2015)
Kathryn E. Pietsch, Paul M. van Midwoud, Peter W. Villalta, Shana J. Sturla, Quantification of acylfulvene- and illudin S-DNA adducts in cells with variable bioactivation capacities. Chemical Research in Toxicology. ,vol. 26, pp. 146- 155 ,(2013) , 10.1021/TX300430R
Wanjuan Yang, Jorge Soares, Patricia Greninger, Elena J. Edelman, Howard Lightfoot, Simon Forbes, Nidhi Bindal, Dave Beare, James A. Smith, I. Richard Thompson, Sridhar Ramaswamy, P. Andrew Futreal, Daniel A. Haber, Michael R. Stratton, Cyril Benes, Ultan McDermott, Mathew J. Garnett, Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells Nucleic Acids Research. ,vol. 41, pp. 955- 961 ,(2012) , 10.1093/NAR/GKS1111
Nicolaas G.J Jaspers, Anja Raams, Michael J Kelner, Jessica M.Y Ng, Yukiko M Yamashita, Shiunichi Takeda, Trevor C McMorris, Jan H.J Hoeijmakers, Anti-tumour compounds illudin S and Irofulven induce DNA lesions ignored by global repair and exclusively processed by transcription- and replication-coupled repair pathways DNA Repair. ,vol. 1, pp. 1027- 1038 ,(2002) , 10.1016/S1568-7864(02)00166-0
Marina Tanasova, Shana J. Sturla, Chemistry and Biology of Acylfulvenes: Sesquiterpene-Derived Antitumor Agents Chemical Reviews. ,vol. 112, pp. 3578- 3610 ,(2012) , 10.1021/CR2001367
Lin Sheng, Yu-Ling Chen, Ke Li, Chuan Qi, Yang Sai, Wei-Guo Su, Ye Hua, Jian-Ming Xu, Jing Li, Ru Jia, Yan Wang, Jian Wang, Molecular Targets and Cancer Therapeutics ,(2015)